Working… Menu

Nab-paclitaxel as Second-line Therapy in Locally Advanced or Metastatic Squamous Lung Cancer

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT01969955
Recruitment Status : Unknown
Verified April 2014 by LI Junling, Chinese Academy of Medical Sciences.
Recruitment status was:  Recruiting
First Posted : October 25, 2013
Last Update Posted : April 25, 2014
Information provided by (Responsible Party):
LI Junling, Chinese Academy of Medical Sciences

No Study Results Posted on for this Study
Recruitment Status : Unknown
Estimated Primary Completion Date : December 2014
Estimated Study Completion Date : June 2015